{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:26:49Z","timestamp":1793726809626,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacl.2024.04.131","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T03:31:20Z","timestamp":1715225480000},"page":"e488-e500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention"],"prefix":"10.1016","volume":"18","author":[{"given":"Merle L.","family":"Myerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-0859","authenticated-orcid":false,"given":"Rodis D","family":"Paparodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-7585","authenticated-orcid":false,"given":"Robert C.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean G.","family":"Karalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot A.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1298-265X","authenticated-orcid":false,"given":"Robert","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.04.131_bib0001","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: pregnancy-Related and Long-Term Health Consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0003","series-title":"Diagnostic Criteria For Polycystic Ovary syndrome: Towards a Rational Approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.jacl.2024.04.131_bib0004","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0006","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jacl.2024.04.131_bib0007","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","article-title":"Racial and ethnic disparities in polycystic ovary syndrome","volume":"119","author":"VanHise","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0008","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2022.01.014","article-title":"Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study","volume":"117","author":"van Keizerswaard","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0009","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacl.2024.04.131_bib0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jacl.2024.04.131_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jacl.2024.04.131_bib0012","first-page":"289","article-title":"Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs","volume":"74","author":"Saadia","year":"2020","journal-title":"Non- Obese Women Med Arch"},{"key":"10.1016\/j.jacl.2024.04.131_bib0013","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.jacl.2024.04.131_bib0014","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.2174\/1381612822666160720150625","article-title":"Adrenal Hyperandrogenism and Polycystic Ovary Syndrome","volume":"22","author":"Luque-Ram\u00edrez","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacl.2024.04.131_bib0015","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jacl.2024.04.131_bib0016","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a Syndrome: genomic Insights Into PCOS Causal Mechanisms and Classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacl.2024.04.131_bib0017","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/dc09-1525","article-title":"Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome","volume":"33","author":"Karakas","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2024.04.131_bib0018","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1530\/EC-17-0218","article-title":"Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome","volume":"6","author":"Crisosto","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jacl.2024.04.131_bib0019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study","volume":"189","author":"Ollila","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacl.2024.04.131_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.552421","article-title":"Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: a Meta-Analysis of Cohort Studies","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacl.2024.04.131_bib0021","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, Challenges, and Guiding Treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0022","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0023","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.2337\/dc21-0437","article-title":"Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: a Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study","volume":"44","author":"Kumarendran","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2024.04.131_bib0024","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacl.2021.03.005","article-title":"Managing cardiometabolic risk factors across a woman's lifespan: a lipidologist's perspective","volume":"15","author":"Gianos","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.04.131_bib0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12020-021-02801-2","article-title":"Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies","volume":"74","author":"Anagnostis","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.jacl.2024.04.131_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0027","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.jacl.2024.04.131_bib0028","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2265.2009.03598.x","article-title":"Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)","volume":"71","author":"Cussons","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0029","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","author":"Kravariti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0030","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacl.2024.04.131_bib0031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacl.2024.04.131_bib0032","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0033","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jacl.2024.04.131_bib0034","article-title":"Current Guidelines for Diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0035","article-title":"Polycystic Ovary Syndrome: pathophysiology and Controversies in Diagnosis","volume":"13","author":"Fahs","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacl.2024.04.131_bib0037","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/nutrit\/nuac075","article-title":"Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials","volume":"81","author":"Moslehi","year":"2023","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jacl.2024.04.131_bib0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13643-019-0962-3","article-title":"Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"8","author":"Kite","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.jacl.2024.04.131_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003883","article-title":"Effects of preconception lifestyle intervention in infertile women with obesity: the FIT-PLESE randomized controlled trial","volume":"19","author":"Legro","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacl.2024.04.131_bib0040","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.soard.2021.04.009","article-title":"Effects of bariatric surgery on patients with obesity and polycystic ovary syndrome: a meta-analysis","volume":"17","author":"Tian","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jacl.2024.04.131_bib0041","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/09513590.2019.1576620","article-title":"Comparison of the effect of two combinations of myo-inositol and d-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial","volume":"35","author":"Mendoza","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jacl.2024.04.131_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.14895","article-title":"Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: a meta-analysis and systematic review of randomized controlled trials","volume":"99","author":"Wu","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0043","first-page":"105","article-title":"Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: a Meta-Analysis","author":"Zhou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0044","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164118825376","article-title":"Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes","volume":"16","author":"DeFronzo","year":"2019","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacl.2024.04.131_bib0045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00404-022-06700-3","article-title":"Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT","volume":"306","author":"Li","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jacl.2024.04.131_bib0046","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0047","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-019-01911-2","article-title":"Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients","volume":"66","author":"Tedesco","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.jacl.2024.04.131_bib0048","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0049","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2265.2001.01245.x","article-title":"Smaller LDL particle size in women with polycystic ovary syndrome compared to controls","volume":"54","author":"Dejager","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacl.2024.04.131_bib0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacl.2024.04.131_bib0051","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.04.131_bib0052","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jacl.2024.04.131_bib0053","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pathol.2018.10.013","article-title":"Diet, exercise and weight loss and dyslipidaemia","volume":"51","author":"Clifton","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.jacl.2024.04.131_bib0054","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.04.131_bib0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.jacl.2024.04.131_bib0056","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2174\/0929867328666210106142912","article-title":"Lipid Metabolism and Relevant Disorders to Female Reproductive Health","volume":"28","author":"Ferrer","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jacl.2024.04.131_bib0057","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2478\/enr-2022-0008","article-title":"Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) - a review of clinical trials and cohort","volume":"56","author":"Melo","year":"2022","journal-title":"Endocr Regul"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T19:49:29Z","timestamp":1724960969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742400179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S193328742400179X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.04.131","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.04.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}